Home > Insider Trading > Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc. (FULC)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q3 2024 Earnings Call Transcript

Operator: Good morning, and welcome to Fulcrum Therapeutics Third Quarter 2024 Financial Results and Business Update Conference Call. Currently, all participants are in a listen-only mode.

Keep Reading →

November 15th, 2024 - News Transcripts

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q2 2024 Earnings Call Transcript

Operator: Good morning and welcome to Fulcrum's Therapeutics Second Quarter 2024 Financial Results and Business Update Conference Call. [Operator Instructions].

Keep Reading →

August 1st, 2024 - News Transcripts

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q1 2024 Earnings Call Transcript

Operator: Good morning and welcome to Fulcrum Therapeutics' First Quarter 2024 Financial Results and Business Update Conference Call. Currently, all participants are in a listen-only mode.

Keep Reading →

May 14th, 2024 - News Transcripts

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q4 2023 Earnings Call Transcript

Fulcrum Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.4, expectations were $-0.44.

Keep Reading →

February 28th, 2024 - News Transcripts

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q3 2023 Earnings Call Transcript

Operator: Good morning and welcome to Fulcrum Therapeutics Third Quarter 2023 Financial Results and Business Update Conference Call. Currently, all participants are in a listen-only mode.

Keep Reading →

November 8th, 2023 - News Transcripts

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q2 2023 Earnings Call Transcript

Operator: Good morning and welcome to the Fulcrum Therapeutics Second Quarter 2023 Financial Results and Business Update Conference Call. Currently all participants are in a listen-only mode.

Keep Reading →

August 11th, 2023 - News Transcripts

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q1 2023 Earnings Call Transcript

Operator: Good morning and welcome to the Fulcrum Therapeutics First Quarter 2023 Financial Results and Business Update Conference Call. Currently all participants are in a listen-only mode.

Keep Reading →

May 17th, 2023 - News Transcripts

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q4 2022 Earnings Call Transcript

Operator: Greetings, and welcome to Fulcrum Therapeutics Fourth Quarter and Full Year 2022 Earnings Conference Call. As a reminder, this conference is being recorded.

Keep Reading →

March 13th, 2023 - News Transcripts

Hedge Fund and Insider Trading News: Bill Ackman, Anthony Scaramucci, Ken Griffin, Skylar Capital Management, K2 Advisors, First Financial Bankshares Inc (FFIN), Deciphera Pharmaceuticals, Inc. (DCPH), and More

Pershing Square CEO Bill Ackman said Hindenburg Research’s report about Gautam Adani’s corporate empire Adani Group is "highly credible" and "extremely well-researched".

Keep Reading →

January 27th, 2023 - Hedge Funds Insider Trading

Hedge Funds Are Crazy About Fulcrum Therapeutics, Inc. (FULC)

Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).

Keep Reading →

January 12th, 2022 - Hedge Funds News